Track topics on Twitter Track topics that are important to you
Disease Progression After Ablation Atrial Flutter Compared With PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Disease Progression After Ablation Atrial Flutter Compared With articles that have been published worldwide.
We have published hundreds of Disease Progression After Ablation Atrial Flutter Compared With news stories on BioPortfolio along with dozens of Disease Progression After Ablation Atrial Flutter Compared With Clinical Trials and PubMed Articles about Disease Progression After Ablation Atrial Flutter Compared With for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Disease Progression After Ablation Atrial Flutter Compared With Companies in our database. You can also find out about relevant Disease Progression After Ablation Atrial Flutter Compared With Drugs and Medications on this site too.
The aim of this study was to study the risk of death and development of arrhythmia and/or subsequently heart failure after an atrial flutter ablation procedure compared with an atrial fibrillation (AF) ablation procedure.
Today, catheter ablation is a widely used treatment for atrial fibrillation (AF) and atrial flutter (AFL). Knowledge on long-term patient-reported outcomes and readmissions is lacking and is warranted to plan optimal follow-up care. Objectives were to describe patient-reported outcomes including perceived health, quality of life, anxiety, depression, and physical activity compared with an age- and sex-matched reference population without longstanding disease; readmissions and mortality; and factors associat...
The potential for thromboembolism in atrial flutter (AFL) is different from atrial fibrillation. AFL cycle length (AFL-CL) may be related to reduced left atrial appendage (LAA) function. Very rapid AFL-CL can lead to mechanical and electrophysiological disorders that contribute to lower LAA emptying velocity (LAEV). The aim of this study is to relate atrial flutter cycle length with LAEV and its role in thrombogenesis.
Radiofrequency ablation has become a safe and effective treatment for atrial fibrillation. We believe that referral to an electrophysiologist for consideration of ablation may allow for better rhythm control and outcomes by altering the natural history of atrial fibrillation progression.
Currently very little is known about the onset, natural progression and management of esophageal injuries after Atrial fibrillation (AF) ablation.
A 67-year-old woman with a history of persistent atrial fibrillation and status post pulmonary vein (PV) isolation and Box ablation isolating the left atrial posterior wall (LAPW), underwent electrophysiological testing of an atypical atrial flutter (AFL) This article is protected by copyright. All rights reserved.
The treatment effect of the hybrid procedure, consisting of a thoracoscopic ablation followed by an endocardial radiofrequency catheter ablation (RFCA), is unclear. A total of 117 ablation-naïve patients who underwent either the staged hybrid procedure (n = 72) or RFCA alone (n = 105) for drug-refractory, non-valvular persistent or long-standing persistent atrial fibrillation (AF) were enrolled. The primary outcome is occurrence of total atrial arrhythmia, defined as a composite of AF, sustained atrial tac...
A 56-year-old man without any structural heart disease underwent a second ablation procedure for a recurrent atrial tachycardia (AT). He had undergone cryoballoon pulmonary vein isolation, left atrial roof, and mitral isthmus linear ablation of atrial fibrillation 2 years prior. This article is protected by copyright. All rights reserved.
Current guidelines support treating atrial fibrillation (AF) and atrial flutter (AFL) as equivalent risk factors for ischemic stroke stratified by CHA2DS2-VASc scores, recommending anticoagulation therapy for patients with a CHA2DS2-VASc score of 2 or higher, but some studies found differences in clinical outcomes.
Ablation of atrioventricular (AV) conduction and pacemaker implantation is the therapy of last resort for symptomatic atrial tachyarrythmias when rhythm and rate control fail, but is far from ideal. To evaluate whether interatrial electrical disconnection as a result of catheter ablation is feasible and of potential clinical utility as a means of non-pharmacological heart rate control.
An increasing number of adults with congenital heart disease (CHD) are undergoing catheter ablation for atrial fibrillation (AF). Data on ablation strategy and outcomes is limited in CHD. Rhythm control is often felt to be of greater importance among patients with complex CHD.
The presence of inducible atrial tachyarrhythmia after pulmonary vein isolation (PVI) during radiofrequency catheter ablation (RFCA) for persistent atrial fibrillation (AF) may indicate the necessity of further substrate modification, but the optimal ablation endpoint is unknown. We sought to assess the impact of procedural termination of inducible atrial tachyarrhythmia after PVI in comparison with continued atrial tachyarrhythmia after PVI.
Left atrial (LA) electro-anatomical remodeling and diameter increase in atrial fibrillation (AF) indicates disease progression and is associated with poor therapeutic success. Furthermore, AF leads to a hypercoagulable state, which in turn promotes the development of a substrate for AF and disease progression in the experimental setting. The aim of this study was to identify pathways associated with LA remodeling in AF patients using untargeted proteomics approach.
Laser balloon (LB) and cryoballoon (CB) ablation are two balloon-based catheter ablation technologies used for atrial fibrillation (AF) ablation in recent years. However, the efficacy and the safety of LB ablation in comparison to CB ablation remained indeterminate. We sought to compare these two technologies by conducting meta-analysis of previous studies using both the CB and LB ablation systems for AF ablation.
Catheter ablation (CA) is a well-established therapeutic option for patients with recurrent symptomatic atrial fibrillation (AF). Data on gender-related differences are limited with regard to baseline characteristics and long-term success rates of catheter ablation for AF.
After 4 decades of innovation, surgical ablation for atrial fibrillation is re-converging on the bi-atrial full Maze procedure as the most effective approach. Contemporary studies suggest that surgical ablation confers significant rhythm and survival benefits without additional operative risk. Alternative energy sources have become standard, focused primarily on radio-frequency and cryothermic energy. With full bi-atrial lesion sets, long-term sinus conversion rates may now approach 90%. Bi-atrial cryoablat...
Ablation index (AI) is a novel ablation quality marker that incorporates contact force (CF), time and power in a weighted formula to provide accurate information about lesion formation during catheter ablation. This index has been evaluated for pulmonary vein isolation (PVI) but has not been systematically used for other left atrial (LA) procedures so far. The aim of this study is to evaluate the feasibility and efficacy of this index for LA anterior line (AL) ablation (LAALA).
Radiofrequency catheter ablation (RFCA) effectiveness in atrial tachyarrhythmias correlates with lesion transmurality. Ablation Index (AI) is an index incorporating contact force, time, and RF power simultaneously, able to predict lesion size and outcomes in atrial fibrillation RFCA.
Growing evidence suggests that second-generation cryoballoon ablation (2G-CB) is effective in patients with persistent atrial fibrillation (PerAF). The cornerstone of atrial fibrillation (AF) ablation is pulmonary vein isolation (PVI). The purpose of this study was to summarize the available data on the safety and mid-term (≥ 12 months) effectiveness of a 'PVI-only' strategy vs. a 'PVI-plus' strategy using 2G-CB in patients with PerAF.
The electrophysiological substrate underlying atrial fibrillation (AF) progression remains difficult to identify.
Data regarding atrial tachycardia (AT) following second-generation cryoballoon ablation (CBA) of atrial fibrillation (AF) are limited.
Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical routine. Left atrial (LA) electro-anatomical remodelling in AF patients indicates disease progression and is associated with poor therapeutic success. PR interval prolongation is associated with an increased risk for AF, however, the association between LA remodelling measured as low voltage areas (LVA) during catheter ablation and PR interval is unknown. The aim of this study was to investigate the association between PR interval ...
The present study was to evaluate the value of CHADS2 and CHA2DS2VASC scores on predicting left atrial (LA) or left atrial appendage (LAA) thrombus in atrial fibrillation (AF) patients prior to ablation in the real world of China.
Catheter ablation is considered as the mainstay treatment for patients with symptomatic atrial fibrillation (AF). We aimed to determine the predictors of 30-day readmission after catheter ablation for AF.